Daihan Pharmaceutical financials at a glance

Year Year 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Rev. Revenue
₩34.67B ₩37.94B ₩41.39B ₩45.84B ₩55.08B ₩67.13B ₩72.65B ₩85.22B ₩96.56B ₩106.80B ₩111.71B ₩124.28B ₩139.44B ₩144.44B ₩158.72B ₩168.76B ₩166.08B ₩171.46B ₩184.27B ₩0.00M ₩0.00M
GM % Gross Margin %
26.62% 26.28% 25.61% 25.12% 25.04% 25.36% 28.11% 27.26% 28.52% 28.13% 30.35% 31.74% 31.00% 37.74% 37.76% 35.08% 33.84% 32.47% 32.46% 0.00% 0.00%
OM Operating Margin
2.90% 1.15% 0.99% 2.75% 3.27% 3.65% 6.59% 8.46% 10.83% 11.78% 12.48% 15.04% 15.58% 22.33% 22.82% 19.93% 18.04% 16.95% 17.89% 0.00% 0.00%
EPS Earnings Per Share
₩1.30k ₩1.36k ₩2.94k ₩4.14k ₩4.75k ₩4.69k ₩2.90k ₩3.78k ₩4.17k ₩4.17k ₩0.00
Div. Dividends
₩0.00 ₩0.00 ₩0.00 ₩0.00 ₩0.00 ₩0.00 ₩0.00 ₩0.00 ₩0.00 ₩0.00 ₩120.00 ₩0.00 ₩220.00 ₩300.00 ₩300.00 ₩400.00 ₩0.00 ₩400.00 ₩650.00 ₩650.00 ₩0.00
PR % Payout Ratio %
0 0 0 0 0 0 0 0 0 0 8.86% 0 7.48% 7.25% 6.31% 8.52% 0 10.59% 15.58% 15.58% 0
Sha. Shares
6m 6m 6m 6m 6m 6m 6m 6m 6m 6m 6m 6m 6m 6m 6m 6m 6m 6m 6m 0m 5.88m
OCF Operating Cash Flow
₩1.38B ₩3.05B ₩381.06M ₩1.95B ₩5.36B ₩3.06B ₩6.41B ₩5.63B ₩11.70B ₩12.69B ₩9.48B ₩17.98B ₩27.92B ₩20.45B ₩44.94B ₩35.26B ₩33.63B ₩40.62B ₩29.00B ₩0.00M ₩0.00M
FCF Free Cash Flow
₩-4573.54M ₩-3505.07M ₩-2792.88M ₩-920.95M ₩1.78B ₩1.65B ₩1.02B ₩2.47B ₩4.81B ₩-6191.45M ₩-986.42M ₩14.01B ₩6.03B ₩-592.25M ₩-1747.75M ₩17.96B ₩28.27B ₩28.77B ₩20.38B ₩27.70B ₩0.00M
FCFS Free Cash Flow Per Share
₩-763.61 ₩-668.19 ₩-465.48 ₩-155.08 ₩295.63 ₩274.12 ₩168.38 ₩406.84 ₩803.98 ₩-1090.39 ₩-165.57 ₩2.34k ₩1.00k ₩-98.71 ₩-291.29 ₩2.99k ₩4.71k ₩4.79k ₩3.41k ₩0.00 ₩0.00